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StoichiometrySulﬁde (H2S) is an inhibitor of mitochondrial cytochrome oxidase comparable to cyanide. In this study,
poisoning of cells was observed with sulﬁde concentrations above 20 µM. Sulﬁde oxidation has been shown to
take place in organisms/cells naturally exposed to sulﬁde. Sulﬁde is released as a result of metabolism of sulfur
containing amino acids. Although in mammals sulﬁde exposure is not thought to be quantitatively important
outside the colonic mucosa, our study shows that a majority of mammalian cells, by means of the
mitochondrial sulﬁde quinone reductase (SQR), avidly consume sulﬁde as a fuel. The SQR activity was found in
mitochondria isolated from mouse kidneys, liver, and heart. We demonstrate the precedence of the SQR over
themitochondrial complex I. This explainswhy the oxidation of themineral substrate sulﬁde takes precedence
over the oxidation of other (carbon-based) mitochondrial substrates. Consequently, if sulﬁde delivery rate
remains lower than the SQR activity, cells maintain a non-toxic sulﬁde concentration (b1 µM) in their external
environment. In the colonocyte cell line HT-29, sulﬁde oxidation provided the ﬁrst example of reverse electron
transfer in living cells, such a transfer increasing sulﬁde tolerance. However, SQR activity was not detected in
brain mitochondria and neuroblastoma cells. Consequently, the neural tissue would be more sensitive to
sulﬁde poisoning. Our data disclose new constraints concerning the emerging signaling role of sulﬁde.chin, 24 rue du Fb St Jacques
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1.1. Sulﬁde and living matter
Sulﬁde is an inhibitor of cytochrome oxidase activity as potent as
cyanide [1]. An aqueous solution of sulﬁde contains hemisulﬁde anion
(HS−) sulﬁde ion S2- and dissolved H2S gas that accounts for 10–30%
of total sulﬁde at physiological pH [2,3]. H2S is uncharged and highly
soluble in lipids [2], therefore it can cross cellular membranes and
reach mitochondria. To defend themselves against excessive sulﬁde
concentrations, cells have no other possibility than destroying or
complexing [3] this poison. However, oceanic ridges are places where
oxidation of this mineral compound is the primary source of energy
[4]. In fact this chemotrophic pathway is thought to be more ancient
than photosynthesis. In mammals sulﬁde is generated either by
biochemical reactions within cells [5] or by bacterial anaerobic sulfur
metabolism in the gut [6]. Adaptation to a sulﬁde-rich environment
has been well studied in invertebrates: it involves oxidation of sulﬁde
at the mitochondrial level [7,8]. Data have been produced showing
that sulﬁde oxidation can also take place in vertebrates and is coupledto mitochondrial bioenergetics [9,10]. We have previously studied
adaptation of colonocytes to sulﬁde [11] and shown that they are able
to oxidize sulﬁde [12]. This was the ﬁrst description of the use of a
mineral substrate by mammalian cells. This metabolic capacity was
thought to represent an adaptation of colonocytes for the survival of
cells in the vicinity of the colonic lumen where sulfate-reducing
bacteria continuously produce sulﬁde. This sulﬁde oxidation involved
a sulﬁde quinone reductase (SQR) activity. A candidate gene exists for
this function in the mammalian genome [13].
1.2. The sulﬁde oxidation unit as known from invertebrates
Fig. 1 shows the relationships between the sulﬁde oxidation
pathway as described in Ref. [8] and the other “usual” pathways of
oxidation in the mitochondrial respiratory chain linked to the use of
carbon-based substrates. It emphasizes that cooperation betweenSQR,
dioxygenase and sulfur oxidase is required and this constitutes
somehow a “sulﬁde oxidizing unit.” Several consequences of this
scheme are relevant here. (i) The stoichiometry between oxygen (O2)
consumption and sulﬁde is 0.75 (1.5 O2 for 2 molecules of H2S). While
0.5 O2 is used at the level of cytochrome oxidase, twice as much (1 O2)
is consumed by the dioxygenase/sulfur transferase pair. (ii) The
capacity for sulﬁde oxidation of a cell with a given phenotype will
depend upon the presence of the sulﬁde oxidizing unit and
Fig. 1. Carbon and sulﬁde oxidation in mitochondria. Oxidation of carbon-based
substrates leads to the reduction of the NAD or FAD coenzymes. The reduced forms of
these coenzymes yield electrons to coenzyme Q of the mitochondrial respiratory chain.
NADH is oxidized by mitochondrial complex I. Reduced FAD coenzymes yield electrons
through different pathways including for example complex II (succinate dehydroge-
nase) and others (symbolized here as a second black box (II). Oxidation of a given
organic substrate involves several steps including NAD and FAD using complexes so that
these two “black boxes” are functionally linked. Inhibition of complex I by poisoning (or
mutation) dramatically reduces overall cellular oxidation (see text and Fig. 2) although
the second black box is unaffected directly. The sulﬁde oxidizing unit acts indepen-
dently. It is constituted of the sulﬁde quinone reductase (SQR) and of two other enzymes
(greyed boxes): a dioxygenase (top) and a sulfur transferase ensuring theﬁnal oxidation
of the two disulﬁdes (-SSH) bound to SQR into oxidized cysteine linked by a disulﬁde
bond. This is the state of SQR able to restart a catalytic cycle.
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(cytochrome oxidase), both of which pump protons to energize the
mitochondrial inner membrane. The subsequent relevant events are
those that control proton return (not shown in Fig. 1): these are the
phosphorylation rate of ADP into ATP by the mitochondrial complex V
and other pathways collectively named “leaks”. (iii) The sulﬁde
oxidizing unit could provide electrons to the respiratory chain in the
absence of any carbon related metabolism inside the cell and
independently of the activity of mitochondrial complex I. In terms of
quantitative bioenergetics, this sulﬁde oxidation pathway is certainly
of marginal importance. However, the severity of the disorders linked
to the loss of the mitochondrial sulfur dioxygenase [14] indicates
clearly the paramount importance of the sulﬁde oxidizing unit.
1.3. Aims and implications of this study
The primary aim of the present study was to introduce an
expression vector with the human candidate gene (SQRDL) coding
sequence into a mammalian cell line in order to check for the function
associated with the sulﬁde quinone reductase activity. Another aim
was to study sulﬁde oxidation in an experimental scheme more
relevant to cellular physiology than the permeabilized preparation
used before (that is more closely related to isolated mitochondria
[12]). Accordingly, living cells with different phenotypes were used.
Surprisingly, our study revealed that addition of sulﬁde to the
incubation medium allowed the detection of relatively high SQR
activity inmany different cell types. This unexpectedlywide scattering
of sulﬁde oxidation has to be considered with relation to the fact that
sulﬁde is now considered as a physiologically relevant molecule with
signaling properties comparable to NO [2,15].
2. Materials and methods
2.1. Chemicals
All chemicals, including sulﬁde, were purchased from Sigma
Chemicals (St. Louis, MO, USA). Each day of the experiment, a fresh
1 M solution of sodium sulﬁde was prepared and diluted to prepareworking solutions of 1–5 mM. At this step, the anhydrous molecular
weight of sodiumsulﬁdewas used as the hydration state of the product
was unknown. Separately, the estimation of the real sulﬁde content
was derived from estimation of the sodium content by ﬂame
spectrometry. The same batch was used for the entire study and the
correction factor was determined to be 0.662.
2.2. Cellular respiration
Cells in suspension were obtained by the action of trypsin 0.25 g/L
in phosphate-buffered saline (PBS) containing 1 g/L EDTA. The cells
were resuspended in their culture medium. Cellular respiration at
37 °C was monitored with an Oroboros “O2k” (http://www.oroboros.
at/index.php?home) equipped with the micropumps to inject sulﬁde
solution at rates ranging between 10 and 80 nl/s for periods of 2–
5 min. Oxygen consumption rates (JO2) were obtained directly from
the Datlab 4 software. The calculations were made using the increase
in JO2 (Δ (JO2) in pmol/(s ml) concomitant with sulﬁde infusion. The
rate of oxygen consumption was usually determined at the end of the
infusion period when the rate was stabilized at a constant value.
When infusion exceeded the maximal sulﬁde oxidation rate of the
cellular preparation, sulﬁde accumulated in the medium, and because
of its toxicity, the respiratory rate went down to the value observed
after complete inhibition of mitochondrial respiration within a few
minutes/seconds. Consequently, when inhibition took place during
infusion, the resulting rates are the mean value of a continuously
decreasing rate. These values might be shown for providing evidence
of inhibition, but were not used in any calculation, as it would be
meaningless. When the concentration dependence was studied single
addition of sulﬁde leading immediately to the expected concentration
were used.
2.3. Cloning and expression of the human SQR
Starting from the sequence present in databases (gbAF042284),
oligonucleotides were designed to amplify the human SQR coding
sequence 5′ oligo (gcatgggatcctgaagATGGTGCCACTGGTGGCTG) and 3′
oligo (ccgcgaattcCTAACTCATACCTAGATGAAACAACTTGC). The SQR
coding sequence was inserted in the pcDNA 3 expression vector
between the BamH1 and EcoRI sites. The resulting expression vector
was sequenced and used to obtain stable transformants of the CHO cell
line. The expression of the human SQR gene was estimated by Q-PCR.
2.4. Isolated mitochondria
Mitochondria from various mouse tissues were prepared by
differential centrifugation in a sucrose preparation medium (Tris
10 mM, EDTA 5 mM, sucrose 250 mM). Mitochondria were resus-
pended in a sucrose respiration medium (Tris 10 mM EDTA 5 mM
sucrose 250 mM; Na Pi 5 mM; BSA 0.1%). Respiration was initiated by
glutamate/malate addition and, when a stable respiratory rate was
recorded, sulﬁde infusion was started.
2.5. Fluorimetry
The reduction state of NADH was evaluated by ﬂuorescence (exc.
340 nm, em. 460 nm), using a Hitachi F2500 ﬂuorimeter with
#15×10e6 cells/ml (THP1 cells) in 2 ml of PBS buffer at 37 °C with
constant stirring. The stirring resulted in single aberrant data points
with a ﬂuorescence value much higher than that of the immediately
preceding and following data points. After importation of the raw data
into Microsoft excel, these aberrant data points were replaced by the
mean value calculated from the immediately preceding and following
data points. This noise reduction procedure was limited so that less
than 10% of the data points were replaced by the mean value of their
immediate neighbours.
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3.1. Characteristics of sulﬁde oxidation in living cells
Fig. 2 shows a typical experiment of sulﬁde oxidation in which the
ﬂux of sulﬁde is determined and the ﬂux of oxygen is calculated from
the decrease in oxygen concentration. The experiments were
performed in the “basal state” of living cells (no agent addition to
the culture medium) or in the presence of rotenone (an inhibitor of
mitochondrial complex I), which reduced oxygen consumption to
about 10% of the basal state. The ﬁrst two infusions of sulﬁde were
accompanied by a concomitant increase in oxygen consumption by
the cells. This increase was ampliﬁed if rotenone was present in the
medium. This provides indirect evidence for the activity of mitochon-
drial sulﬁde quinone reductase and is thus in complete agreement
with the established scheme (see Introduction) andwith our previous
publication [12]. However, the cells used here were CHO cells
(hamster ovarian epithelial cells) and not colonocytes, demonstrating
the presence of a quantitatively signiﬁcant sulﬁde quinone reductase
activity in these cells unrelated to the digestive tract.
Fig. 2 shows that further increase of the injection rate of sulﬁde
resulted in an increase in oxygen consumption that lasted longer than
the injection period. This indicates that sulﬁdewas accumulated in the
medium because the infusion rate exceeded the maximal sulﬁde
oxidation rate of the cellular preparation. In these conditions, the
oxygen consumption ratewas not stable and after an initial increase, it
decreased down to a minimal value and increased again until the ﬁnal
drop restoring the oxygen consumption rate in the absence of sulﬁde.
This indicates a partial inhibition of respiration by the sulﬁde
accumulated in the medium. When this inhibition starts it is self-
ampliﬁed as it decreases the oxidative sulﬁde disposal rate while
infusion continues.
In the same experiment, the same quantity of sulﬁde was also
added as a single shot which resulted in a 26 µM concentration in the
incubation medium. In the absence of rotenone, this resulted in an
immediate inhibition of cellular oxygen consumption with a decrease
down to 25% of the value recorded before this addition. However,
cellular sulﬁde disposal still took place, and after a long period cells
recovered a sub-normal respiratory rate. The same single addition of
sulﬁde in the presence of rotenone caused an increase in oxygen
consumption, which lasted much less than the inhibition phase in the
absence of rotenone. The conclusions are: (i) although a severe
poisoning of the cellular respiration occurred, the process of sulﬁde
elimination still took place through an oxygen consuming pathway.
(ii) The shorter time needed for sulﬁde elimination in the presence of
rotenone reveals a negative interaction between sulﬁde oxidation andFig. 2. Cellular respiration in presence of sulﬁde. CHO cells resuspended in their culture me
black, “basal state” (no addition); gray, cells poisoned by 5 µM rotenone (mitochondrial com
quantity of sulﬁde added as well as the injection rate are indicated.mitochondrial complex I activity. However, no such negative
interaction could be deduced from the previous infusions of sulﬁde.
The reason for that will be presented below.
3.2. Numerous mammalian cell types oxidize sulﬁde
The presence of SQR activity was examined in a variety of
mammalian cell lines (Fig. 3). As the injection of sulﬁde caused an
increase in cell oxygen consumption in the absence of any other
addition (Fig. 2 black line), we decided to evaluate the cellular sulﬁde
oxidation capacity in this basal state of respiration, and not in the
presence of rotenone, because in physiological conditions, cells would
occasionally have to deal with sulﬁde while having a normal
respiratory activity. To facilitate comparison between cell prepara-
tions (Fig. 3), we used the following units: the stimulation of
respiration relative to the initial respiratory rate (without sulﬁde)
and a “relative sulﬁde exposure,” given by the ratio between sulﬁde
infusion rate (pmol/(s ml)) and the initial respiratory rate (same
units). Two types of cell lines were easily distinguished: a vast
majority (12 cell types out of 16) showed a stimulation of respiration
during sulﬁde addition while others (4 cell types) did not. The
distinction could be easily seen at a relative sulﬁde exposure of 0.5 for
which positive cells increased their oxygen consumption by about 25%
(Fig. 3 histogram) whereas “negative cells” did not show any
signiﬁcant increase. In fact, with “negative cells,” inhibition of
respiration often occurred well below this relative sulﬁde exposure.
As expected, the human colonic carcinoma cell line HT-29 showed the
highest SQR activity, but surprisingly the human monocyte (THP1)
cell line and a primary culture of human myoblasts showed a high
SQR activity, even slightly higher than the other colonic epithelial cell
line CaCo2. The two different neuroblastoma cell lines examined
proved to be negative. An experiment with two cell lines originating
from plants (carrot, tobacco) showed no detectable SQR activity (data
not shown).
3.3. Recombinant expression of human SQR in CHO cells
The cDNA for the human Sqrdl gene homologous to bacterial SQR
enzyme [13] was introduced in a mammalian expression vector and
the stable transformants of CHO cells obtainedwere examined for SQR
activity (Fig. 4). When the clones expressing the highest level of
SQR were compared to control clones, the oxygen consumption in-
creased almost linearly with sulﬁde injection rate in the SQR
transformants, while the control clones could hardly increase their
oxidation rate and undergo inhibition of cellular oxidation with the
highest sulﬁde infusion rate (Fig. 4A). This conﬁrms that the Sqrdldium. X axis, time in minutes; Y axis, oxygen consumption by the cellular suspension;
plex I is fully inhibited). The periods of sulﬁde infusion are shown as grayed bars, the
Fig. 3. Stimulation of cellular respiration by sulﬁde in various cell types. Top: the data points obtained with the different cells types (except HT-29). X axis: JNaHS/initial JO2 ratio
where JNaHS is the ﬂux of sulﬁde in pmol/(s ml) and initial JO2 the oxygen consumption of the cellular preparation in the absence of sulﬁde (same units). This is a dimensionless
number that quantiﬁes the relative sulﬁde exposure independently of the density of the cellular preparation. Y axis: stimulation of respiration (x initial JO2), white dots cells showing
SQR activity, black sulﬁde intolerant cells showing no detectable SQR activity. Experiments were stopped when inhibition of cellular oxygen consumption was observed. The data
points situated between the dotted lines were used to draw the histograms shown on the left. Bottom: The different cell types examined are indicated with the maximal value of
stimulation of oxygen consumption (third column) and the relative sulﬁde exposure at which it occurs (fourth column). The name of established cell lines is indicated, otherwise
these cells are coming from primary culture (p.c.) or locally immortalized cell lines (i.c.l.). Inverted characters: cell types considered as sulﬁde intolerant. HT-29: 5 independent
experiments, CHO cells: 3 independent experiments, the others: one experiment (in triplicate). However, Jeg3 cells were used as a negative control in several other experiments and
THP1 in other experiments (Figs. 5 and 11).
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abundance as a limiting factor for the sulﬁde oxidation capacity in the
CHO cells. It was duly checked that both with endogenous or
recombinant SQR this mitochondrial oxidation of sulﬁde is coupled
to ATP synthesis (Fig. 4B).
3.4. Concentration dependence
The Jeg3 cell line showing no detectable SQR activity was used to
deﬁne the toxic concentration of sulﬁde in our experimental
conditions. A concentration of 20 µM sulﬁde resulted in half inhibition
of cellular oxygen consumption of the Jeg3 cells (Fig. 5A). To estimate
the concentration of sulﬁde in the medium triggering the cellular
oxidation by SQR, the CHO-J cell line expressing the highest level of
human SQR was used. A sublinear increase in cellular oxygen
consumption was observed for concentrations of sulﬁde in the
range 2–10 µM (Fig. 5 bottom). It remains uncertain whether or not
stimulation of cellular oxygen consumption (sulﬁde oxidation) took
place when the concentration added was below 2 µM. In other
experiments we could estimate with the human monocyte cell line
THP1 that the threshold at which sulﬁde oxidation starts is between
0.5 and 1 µM in the external medium (supplementary information 1).
For the sake of simplicity, we will refer hereafter to a 1 µM thresholdfor SQR activity. It is important to bear in mind that technical
limitations made this estimation the maximal value for this threshold.
Although cytochrome oxidase is not expected to be less sensitive to
sulﬁde when cells are equipped with SQR, when 20 µM sulﬁde was
added to the SQR expressing cells CHO-J, the oxygen consumption
was further increased although this parameter was not linear
anymore under such an experimental condition (Fig. 5 bottom).
Several reasons would explain this result: Firstly, according to the
reaction scheme (Fig. 1), sulﬁde oxidation results in an increase of
oxygen consumption, two thirds of which are not due to cytochrome
oxidase activity. Secondly, this rate is the mean value of the transient
increase recorded after the sulﬁde addition. Hence, it occurs during a
continuous decrease in sulﬁde concentration from the desired value
down to zero (in fact the threshold value). It is therefore impossible
without a continuous measurement of actual sulﬁde concentration in
the incubation medium (not presently feasible) to investigate what
sulﬁde oxidation ratewould occur if a stable sulﬁde concentration (for
instance 20 µM) were maintained during the experiment. However,
based on our observations, we propose that a range of sulﬁde
concentrations between 10 and 40 µM represents a reasonable
estimation of the range for which a transition between a moderately
impaired and a complete inhibition of mitochondrial bioenergetics
takes place. Lower sulﬁde concentration i.e. in the 1–5 µM range,
Fig. 4. Recombinant expression of the human SQR in CHO cells. A) Oxidation of and
tolerance to sulﬁde: The graph shows the mean value±s.e.m. of absolute increase in
respiratory rate Δ(JO2) in pmol/(s ml) caused by the infusion of sulﬁde. Filled bars: The
stimulation observed with four control CHO cell lines transfected with the empty vector
(2 clones) or expressing the UCP2 mitochondrial protein (2 clones), mean cell density
1.39×106/ml, mean oxygen consumption rate 98 pmol/(s ml). Empty bars: The six
stable transformants of CHO cells with the highest levels of expression of human SQR,
the mean cell density was 1.39×106/ml with a mean oxygen consumption rate in
absence of sulﬁde of 105 pmol/(s ml). Sulﬁde injection rate is indicated above
histograms (same unit as Δ(JO2)). The number of measurements is indicated on
histogram bars. Themeasurements at 33 and 66 values of sulﬁde infusion rates involved
all these clones. However only 3 of the four control clones were examined at 132 pmol/
(s ml). The p values (unpaired t-test) are indicated. B) Coupling of sulﬁde oxidation to
phosphorylation: Y axis: oxygen consumption (JO2) of the cellular preparation, X axis:
Sulﬁde infusion. A clone of CHO cells transfected with the empty vector (black symbols)
and the CHO-J cellular clone (white symbols) grown under identical conditions are
shown. The basal cellular respirationwas recorded and then rotenone (5 µM)was added
to inhibit mitochondrial complex 1 activity. The sulﬁde was infused at increased rates in
absence (circles) or in presence of 0.5 µg/ml of the mitochondrial FoF1 ATPsynthase
inhibitor oligomycin (triangles). The data shown comes from a single experiment but
similar experiments were repeated (but paired +/- rotenone) for the calculation of
stoichiometry as shown in Fig. 7.
Fig. 5. Inhibition and activation of cellular respiration by sulﬁde. Top: Inhibition of
respiration in Jeg3 cells: Jeg3 cells are unable to oxidize sulﬁde: in separate experiments,
it was shown that there is no detectable oxygen consumption acutely triggered by
sulﬁde addition in presence of rotenone. The oxygen consumption of Jeg3 cells was
recorded in presence of increasing concentration of sulﬁde (acute addition from 0.5 to
40 µM: X axis) in ﬁve experiments (three independent cell preparations). The ratio
between oxygen consumption in presence/absence of sulﬁde is shown as % ± mean
deviation (Y axis). Exponential ﬁtting is shown. Bottom: Concentration dependence of
sulﬁde oxidation in the recombinant CHO-J cell line expressing the highest level of
human SQR. Cells were poisoned with rotenone before sulﬁde addition. The same units
as above are used for the X axis (note the different scale), Y axis: increase in Δ(JO2) in
pmol/(sml) caused by sulﬁde addition. Data are presented asmean±mean deviation of
four experiments (two independent cell preparations). The grey line reproduces the
exponential ﬁtting of the upper graph for comparison of inhibition range with the
activation range.
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signiﬁcant cytochrome oxidase inhibition.
3.5. Oxidation of sulﬁde by mitochondria from mouse organs
To check whether oxidation of sulﬁde by cultured cells has a
counterpart in vivo, mitochondria from mouse organs (liver, heart,brain and kidney) were examined. When these mitochondria were
challenged with sulﬁde infusion, sulﬁde oxidation due to SQR activity
could be found in kidney, heart and liver, but appeared to be absent or
extremely low in brain (Fig. 6). This agrees with the conclusion that
SQR is present in many types of mitochondria as indicated by the
studies with cell lines and conﬁrms a defect of sulﬁde oxidation in
neural tissues. This experiment demonstrates that the presence of an
active SQR in cell lines does not result from a qualitative modiﬁcation
of cellular metabolism brought on by immortalization or culture
conditions. No optimization of the protocol was attempted and
Fig. 6. Oxidation of sulﬁde by isolated mitochondria. The graph shows the absolute
increase in respiratory rate Δ(JO2) in pmol/(s ml) observed during sulﬁde injection at
the rate indicated below the X axis (same units): mean values ± mean deviation
obtained with three independent mitochondrial preparations. The mean values of
oxygen consumption were respectively 151, 50, 84 and 84 pmol O2/(sml) for the brain,
liver, heart and kidney mitochondrial preparations.
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organs, their quantitative analysis remains beyond the objective of
this study.
3.6. Stoichiometry of oxygen to sulﬁde
In the experiment shown in Fig. 2, oxygen consumption was
measured and the sulﬁde infusion rate was controlled. The ratio
between the increase in oxygen consumption and the sulﬁde infusion
rate allowed calculation of the experimental oxygen to sulﬁde
stoichiometry (Fig. 7). When the cellular preparation has reached its
maximal sulﬁde oxidation rate, a moderate increase in sulﬁde infusion
would decrease the ratio before any detectable inhibition of oxygen
consumption occurs. Consequently, the decrease in calculated
stoichiometry is an indication of the saturation of the sulﬁde oxidation
pathway by the ﬂux of sulﬁde imposed to the cells. This is best
illustrated by the differences between the control CHO cells and CHO
cells expressing human SQR. In the presence of rotenone, the cells
with a high sulﬁde oxidation capacity showed over a wide range of
sulﬁde injection rates a stable stoichiometry value between 0.74 and
0.89, equal to or slightly above the theoretical 0.75 value derived from
the reaction scheme (Fig. 1). In the “basal state”, the value ranged
from 0.5 to 0.64 and remained constant over a more restricted range
of injection rates, conﬁrming the negative interaction between
mitochondrial complex I and the sulﬁde-oxidizing unit.
With CHO and THP1 cells and in the presence of oligomycin, the
stoichiometry approached the value in the presence of rotenone and
declined at signiﬁcantly lower rates of sulﬁde infusion. This earlier
decline is evidence for the mitochondrial coupling. In contrast, for the
colonic epithelial cell line HT-29, the stoichiometry in the presence of
oligomycin remained barely modiﬁed in comparison with the “basal
state” indicating an uncoupled state of mitochondrial respiration in
the presence of sulﬁde.
3.7. Sulﬁde oxidation is accompanied by an increase in the NADH/NAD
ratio
The effect of rotenone with a saturating amount of sulﬁde
suggested that mitochondrial complex I rendered sulﬁde oxidation
slower (right end of Fig. 2). To check if the inverse is true the
reduction state of NAD/NADP coenzymes was evaluated by ﬂuores-cence (Fig. 8A). First sulﬁde injections caused no inhibition of oxygen
consumption (Fig. 8B) the last one (double dose) caused inhibition.
Both doses of sulﬁde led to an increase in ﬂuorescence indicating
further reduction of NAD coenzymes. Inhibition of the mitochondrial
respiratory chain results in the increase in the NADH reduction rate
(see effect of rotenone in Fig. 8A). In this respect the sole observation
of the increase in NADH is not a direct proof of a direct competition
between SQR and complex I. However, a kinetic argument could
be put forward: upon sulﬁde addition an immediate increase in
ﬂuorescence occurred, this increase appeared to be the same with the
low and high sulﬁde additions. This increase was followed by a
decrease in the case of low addition and by a slow increase
concomitant with the oxygen consumption decrease in the case of
the high addition of sulﬁde. This slower increase led to ﬂuorescence
value close to that obtained with the complete inhibition of
mitochondrial complex I with rotenone. It appears therefore likely
that the onset of the sulﬁde oxidation by SQR had the immediate
consequence to set the NADH/NAD ratio to a new value at which
complex I could still drive electrons in the respiratory chain while SQR
operates. Then according to the sulﬁde concentration present the
inhibition of cytochrome oxidase would take place or not.
3.8. Rotenone recouples sulﬁde oxidation in colonocytes
The comparisonof themaximumﬂuxes of oxygen and sulﬁde in the
HT-29 cells are compared in Fig. 9. In the presence of rotenone (white
bars), the addition of oligomycin reduced the amount of oxygen
consumed, an effect which was not observed in the absence of
rotenone (black bars). Therefore, in the absence of rotenone,
mitochondrial respiration was largely uncoupled and addition of
rotenone restored the coupling. The changes in stoichiometry caused
by rotenone or oligomycin (Fig. 7) could be misleading, and at least
complicate the ﬁgure with regard to a normal coupled/uncoupled
transition where the difference should be seen in the presence of
oligomycin (Fig. 9 top right) but not in its absence (Fig. 9 top left). The
maximal sulﬁde consumption rate is not subject to this complication.
Consistent with the oxygen data, the decrease induced by oligomycin
is greater and becomes statistically signiﬁcant only in the presence of
rotenone (Fig. 9 bottom).Moreover, in the presence of oligomycin, the
maximal sulﬁde oxidation rate is decreased when complex I is
inhibited by rotenone (Fig. 9 bottom right). Consequently, in the
presence of oligomycin, the presence of a functional complex I
increased sulﬁde oxidation by SQR in HT-29 cells. This contrasts
sharply with the other cell types where the use of rotenone revealed
that mitochondrial complex I had adverse effects on the SQR activity
(Figs. 2, 7).
4. Discussion
4.1. Physiological concentrations of sulﬁde
Themitochondrial sulﬁde oxidation takes placewithin living cells if
the concentration of sulﬁde in the medium is above a threshold
estimated in the 0.5–1 µM range. The cells have therefore a rather high
afﬁnity for sulﬁde. Actually, the afﬁnity of the SQR enzyme is even
higher and was estimated to be lower than 0.1 µM in permeabilized
HT29 cells [12]. Although the ﬂux of sulﬁde oxidation can be high [12],
its concentration has to be maintained very low since 0.3 µM in the
vicinity of mitochondrial cytochrome oxidase is sufﬁcient for half
inhibition of this enzyme [11]. Therefore, the concentrations
evidenced previously with permeabilized cells or enzymatic prepara-
tions (b0.3 µM) differ from those evidenced here 1–10 µM (Fig. 5) by
at least an order ofmagnitude. In all our experiments, sulﬁdewas given
as the sodium salt of the hemisulﬁde (HS−) anion that by protonation
can generate H2S. While H2S is permeant, the plasma membrane and/
or its potential (negative inside) is a barrier to anion entry. It is unclear
Fig. 7. Stoichiometry of Oxygen to Sulﬁde consumption. Y axis: the stoichiometry (oxygen to sulﬁde) is calculated from the ratio between the increase in oxygen consumption
associated with sulﬁde infusion and sulﬁde infusion at different rates of sulﬁde injection in pmol/(s ml) (X axis). Mean values ± mean deviation. N=3 (three independent cellular
preparations), except for HT-29: n=9measurements (with ﬁve independent cellular preparations). Empty circles: respiration in presence of rotenone (sulﬁde only). Black symbols:
respiration in absence of rotenone (organic substrates and sulﬁde), in absence of oligomycin (circles) or in its presence (triangles). The dotted lines underline the data points used for
calculation of the stoichiometry (O2/Sulﬁde) in absence or presence of rotenone. These values are shown on the right. Paired experiments were performed in presence/absence of
rotenone. The paired t-test gave a p value equal to 0.001 for the CHO control cell line and lower than 10−7 for the others for the difference in stoichiometry in presence/absence of
rotenone (white/black circles).
1506 E. Lagoutte et al. / Biochimica et Biophysica Acta 1797 (2010) 1500–1511if sulﬁde oxidation by SQR or inhibition of cytochrome oxidase needs
entry into mitochondrial matrix. If so, the high potential of the
mitochondrial inner membrane could exclude further sulﬁde from
reaching its target(s). This shielding effect of the cellular membrane is
likely to explain the differences in concentrations noticed above (see
also supplementary information 2).
The present study shows that there is within the mammalian body
a signiﬁcant amount of mitochondria in different cell phenotypes
which are able to oxidize sulﬁde in addition to the colonic epithelial
cells. This suggests a selective pressure for its maintenance even if the
animals/cells have escaped from a sulﬁde containing external
environment. This is likely to be explained by the fact that sulﬁde, an
inhibitor of cytochrome oxidase with the same potency as cyanide,
remains a permanent threat to aerobiosis due to the continuous use of
sulfur containing molecules by living matter [5,16]. The sulﬁde
production rate has been estimated [17,18]. For instance, in Ref. [18],
the sulﬁde production rates were estimated to be 2 and 5 nmol g−1
min−1 in aorta and heart, respectively. This allows one to presume that
sulﬁde concentration would rise by 2 or 5 µM per minute (assumingthat 1 g corresponds to 1 ml) unless sulﬁde is consumed. Therefore, if
these experimental values reﬂect physiological reality, withinminutes
aorta or heart would release enough sulﬁde to poison themselves.
Consequently, detoxiﬁcation of sulﬁde is required and mitochondrial
oxidation by SQR would do so. The oxygen consumption linked to
sulﬁde oxidation represents 0.75 of the sulﬁde production rate hence
1.5–4 nmol O2 g−1 min−1 for the sulﬁde production rates indicated
above. The oxygen consumption rates of a beating mouse heart are in
the 10,000 nmol O2 g−1 min−1 range [19], whereas a value of
180 nmol O2 g−1 min−1 was given for resting myocardic tissue [20].
Therefore, sulﬁde oxidation appears to constitute a marginal contri-
bution to the cellular oxygen consumption and mitochondrial ATP
production. Our experiments could easily detect the increase in
oxygen consumption linked to sulﬁde addition because it was of the
same order of magnitude as that of the basal oxidative metabolism of
the cells/mitochondria in the absence of sulﬁde (Figs. 2, 4–6). Hence,
the SQR activity present in cells or in mitochondria appears to be in
large excess with regard to the expected endogenous sulﬁde
production rates. Hydrogen sulﬁde is a gas that diffuses freely across
Fig. 8. Sulﬁde oxidation increases the reduction state of NADH. A) The reduction state of NADH was evaluated by ﬂuorescence. The different additions are indicated. B) Recording of
the oxygen consumption of THP1 cells in the same conditions (same cell preparation) and same additions: thin line represents oxygen concentration, thick line represents oxygen
consumption (JO2). This is the unmodiﬁed graph from the oxygraph software. Horizontal bars indicate equivalent periods of time in the two graphs.
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meet a sulﬁde oxidizingmitochondrionwithin a short time.Moreover,
our study showed that immune cells such as macrophages or
monocytes scattered over or circulating within the whole body show
a high sulﬁde oxidation capacity. Accordingly, within a short range
around any sulﬁde producing source, the concentration of sulﬁde in
the extracellular mediumwould not be higher than the SQR threshold
(≤1 µM). In this respect our data agreewith the recent conclusion that
the global sulﬁde concentrationswithin tissues are considerably lower
than previously thought [21]. Another possibility has been put forward
to explain why sulﬁde concentration remains low in the body and
would constitute a second line of defence against sulﬁde toxicity [3].
According to these authors the added free sulﬁde is converted into a
bound form of sulfur stored within cellular components. This bound
form can be released by the action of reducing agent or pH changes.
This has been well demonstrated using the brain tissue, but the
demonstration of the reversibility of binding is missing using liver or
heart homogenate, while both showed a considerably faster rate of
sulﬁde disappearance. The comparison with results obtained with
isolated mitochondria (this study) leaves open the possibility that in
the experiment shown in Ref. [3] with liver and heart homogenates,
sulﬁdewas in fact quickly oxidized by the SQR, something not possible
with the brain homogenate. Accordingly, although this bound form of
sulfur is likely to represent a source of sulﬁde relevant for cellular
signaling, we propose that its formation by combination of free sulﬁde
is a less efﬁcient line of defense against sulﬁde toxicity in comparison
with the fast-acting SQR.
Our study deﬁned three domains for the external concentration of
sulﬁde according to the state of SQR and cytochrome oxidase. At
concentrations lower than the threshold (≤1 µM), external sulﬁde isnot made available for the intracellular SQR. Between 1 and 10 µM,
sulﬁde is oxidized as a fuel by cells if SQR is present. When
concentrations rise above 10 µM, inhibiting effects become increas-
ingly relevant and are complete above 40 µM. Cells therefore have to
recruit other mechanisms than aerobic oxidation by the mitochon-
drial cytochrome oxidase to extract energy from their substrates. Even
if complete inhibition of cytochrome oxidase is taking place, sulﬁde
disposal still occurs but at a considerably reduced rate.
4.2. Sulﬁde oxidation and the physiological roles of sulﬁde
Concerning the physiological roles of sulﬁde, bibliographic data
indicate a signaling role similar to NO [2], an antioxidant role [22], a
role in the induction of a suspended animation state in rodents [23]
and ﬁnally a role in oxygen sensing [24]. All these observations raised
interest and the therapeutic use of sulﬁde has been envisaged [15].
Sulﬁde signaling requires a source of sulﬁde and a cellular target.
Our experiments showed two issues depending on the relative
importance of sulﬁde delivery with respect to sulﬁde oxidation: (i) If
sulﬁde production is to be maintained below the cellular oxidative
capacity, sulﬁde concentration should be in the lowmicromolar range
(see above). (ii) If sulﬁde production saturates the oxidation pathway,
sulﬁde accumulates, and inhibition of mitochondrial respiration
occurs when the external concentration rises above a critical
concentration (N40 µM). However, mechanisms which metabolize
sulﬁde still take place and cessation of sulﬁde delivery allow
detoxifying mechanisms (or diffusion) to lower sulﬁde concentration
and thus respiration to resume. Consequently, if the SQR is the sole/
major pathway for sulﬁde disposal, any external concentration below
the threshold value (≤1 µM) can be maintained. The afﬁnity of SQR
Fig. 9. Maximal oxygen and sulﬁde ﬂuxes in HT-29 cells. Top: maximal increase in
oxygen consumption Δ(JO2) caused by sulﬁde oxidation in the absence (black) or
presence (white) of the complex I inhibitor rotenone and in the absence or presence of
the FoF1 ATPsynthase inhibitor oligomycin. These are the mean values±SEM of nine
measurements made during ﬁve independent experiments. Bottom: Maximal ﬂux of
sulﬁde oxidized by the same cells: same units and same legend. The italicized characters
above histograms indicate the p values of the paired t-test between values in the
presence/absence of rotenone. The italicized characters on the right of the histogramare
the p values of the unpaired t-test between values in the presence/absence of
oligomycin. Numbers inwhite on the left of the histograms are the stimulation factor for
respiration (top) and the relative sulﬁde exposure (bottom) for their comparison with
the prediction of the model (Fig. 10).
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rates (see above) make the SQR a major opponent to any process
susceptible to increase sulﬁde concentration above this threshold
value. However, if by any chance sulﬁde concentration would rise
above 40 µM, the inhibition of mitochondrial oxidative metabolism
would make SQR considerably less efﬁcient; and maintenance of this
high concentration of sulﬁde would be associated with much lower
rates of sulﬁde delivery. In the hypothesis of a single sulﬁde addition,
there would be a critical zone (10–40 µM) in which the time needed
for sulﬁde disposal increases abruptly in a non-linear way (see, for
example, Figs. 2 and 8). These considerations have important
consequences with regard to the physiological properties of sulﬁde
presented so farwhich are related to a signaling role for this compound
and to its capacity to induce a suspended animation state [15,23].
Following the description of NO as a gaseous signaling molecule
[25] and after pioneering work indicating the relevance of sulﬁde inthe learning process and in vasorelaxation [26,27], sulﬁde has gained
credit as a meaningful gaseous messenger during the past decade
[17,18,28]. A recent review on these gaseous messengers and their
relationship with amino acid metabolism is found in Ref [29]. The
“signaling concentrations” that were used are reviewed in Ref. [15]. In
the cellular models, the concentrations are in the 10 µM to 3 mM
range. The lowest concentrations are therefore overlapping with the
critical concentration range as indicated above while the highest
concentrationswould impair severely and immediatelymitochondrial
bioenergetics. This would have immediate consequences on muscular
tone and/or K+-ATP channels. The coincidence of the inhibiting effect
of sulﬁde on respiration with its protecting role on mitochondrial
function during ischemia reperfusion has been noticed [30], pointing
to a possible overlap/confusion between signaling and inhibition of
oxidative metabolism. Therefore in quite a few cases, the sulﬁde
administration would have the same bioenergetical consequences
than a period of ischemia, with the difference that the mitochondrial
bioenergetics would be gradually restored following the decrease in
sulﬁde concentration with time. This decrease could be due to SQR
activity, binding to cellular components, and to chemical instability of
sulﬁde solution. A non-lethal period of ischemia triggers cellular
responses (preconditionning) aiming at increasing resistance to the
deleterious consequences of ischemic shock. These deleterious
consequences include oxidative stress. In this respect it is worth
noticing that exposure of neurons to sulﬁde protects them against the
oxidative stress caused by external glutamate [22]. The mechanisms
include an increase in cellular glutathion, which outperforms the
direct antioxidant property of sulﬁde itself [22], and appeared to be
mediated by the K-ATP channels [31].
The SQR activity is likely to be present inmany cell phenotypes and
this activity would cause a decrease of sulﬁde external concentration
down to the 1 µM limit i.e. at a pace heavily inﬂuenced by the sulﬁde
amount to cell ratio. This further complicates the comparison between
data obtained using different experimental protocols. While pharma-
cological use of sulﬁde does not prove that sulﬁde has a role in
physiology, this role is now supported by the observation that mice
where one sulﬁde producing enzyme has been invalidated show
hypertension [18].
The signaling role of sulﬁde has to be considered in the context of
our present results which indicate that monocytes present in blood
and a large part of the surrounding tissues (muscle, and conjunctive
tissue for example) should be able to maintain a sulﬁde concentration
below 0.5–1 µM in the extracellular medium. Therefore, our data and
calculation are in agreementwith [21], but are against the estimate of a
40 µM free sulﬁde physiological plasma concentration, since this
would severely poison cellular aerobic metabolism. Two possibilities
can be envisaged: ﬁrstly, sulﬁde concentrations below the threshold
for SQR activity do have signaling properties, or secondly sulﬁde
signaling concentrations arewithin the rangewhere SQR operates. The
ﬁrst possibility means that signaling would occur with sulﬁde
concentrations below 1 µM in the extracellular medium, and ten
times less within the cell. Then SQR would simply represent a way to
avoid a rise of sulﬁde to toxic levels. If this is true, somany studies have
used sulﬁde at such concentrations that it creates some confusion
regarding the effects of sulﬁde on cellular bioenergetics and the effects
of sulﬁde in the signaling process. The second possibility is that the
concentrations required for a sulﬁde signaling role overlap with those
relevant for SQR and mitochondrial bioenergetics. This opens up the
possibility that SQR and mitochondrial bioenergetics participate in
this signaling. It isworth noting that the situation is different according
to the presence/absence of SQR in the target cell. If present, the SQR
activity would ensure extinction of the signal and guarantee its
conﬁnement to speciﬁc locations close to the sulﬁde source. In this
respect the defect of sulﬁde oxidation capacity as evidenced in the
neural tissue (this study) is of importance because itwould correspond
to an extension both in time and space of the inﬂuence of sulﬁde
Fig. 10.Model for sulﬁde and carbon oxidation in mitochondria. Top: a schematic view
of the relationships between carbon and sulﬁde oxidation. Organic substrates' oxidation
is schematized as a ﬁrst step providing NADH and FADH2 to relevant complexes of
respiratory chain (black box). Sulﬁde oxidizing unit with the sulﬁde quinone reductase
(SQR) and associated enzymes (grey box). The output of electrons from the quinone
pool (Q) towards complexes III and IV (cytochrome oxidase c=cytochrome c) remains
constant. Consequently the entry of electrons coming from sulﬁde results in a decrease
of the ﬂux of electrons coming from carbon oxidation. This inhibition is emphasized by
the dotted line. Bottom: quantitative analysis of the components of oxygen consumption
at different sulﬁde oxidation rates expressed relatively to the cytochrome oxidase rate
(Jsulﬁde/JO2 cytox). This unit is congruent with the relative sulﬁde exposure (JNaHS/
initial JO2).
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brain might be relevant in the induction of the suspended animation
state.
4.3. Mammalian mitochondria prefer sulﬁde “mithridatochondria”
The oxidation of sulﬁde is achieved by a sulﬁde oxidizing unit
constituted of three enzymes [8]. The entry of sulﬁde takes place
through the sulﬁde quinone reductase (SQR) andwe demonstrate that
the human candidate gene indeed codes for a functional SQR. The
reaction scheme [8] imposes a stoichiometry of oxygen to sulﬁde of
0.75. Experimental determination of oxygen to sulﬁde stoichiometry
remained consistent with this value of 0.75 when mitochondrial
complex I was poisoned with rotenone (Figs. 1, 2, 7) and consequently
sulﬁde alone was oxidized. The model shown in Fig. 10 explains how
stoichiometry in the absence of rotenone (basal state) was lowered to
0.5. This model states that the ﬂux of electrons reaching oxygen in the
mitochondrial respiratory chain is unchanged whether sulﬁde is
oxidized or not. Consequently, the injection of electrons by the SQR
causes a decrease in the output of electrons from other substrates
(mainly complex I). Accordingly mammalian mitochondria showed
more afﬁnity for the mineral substrate and also poison sulﬁde than for
their “normal” carbon derived substrates. This may recall the strategy
used a long time ago by the king Mithridate VI Eupator (132-63 BCE)
who attempted to get protection against poisons by absorbing limited
doses of them. Consequently, a redox change/stress results from the
SQR activity before the inhibition of the cytochrome pathway (Fig. 8).
This precedence of SQR over complex I is not complete and the activity
of complex I impedes SQR from reaching its maximal rate. This is
deduced (i) from the threshold at which stoichiometry values started
to decrease in the absence/presence of rotenone (Fig. 7), (ii) from the
time needed to oxidize a large excess of sulﬁde in the presence/
absence of rotenonewith CHO cells (Fig. 2) and (iii) from the variation
of stoichiometry in the presence of oligomycin, which has driven the
stoichiometry to values close to that calculated in the presence of
rotenone (Fig. 7 CHO and THP1). Therefore, in the presence of
oligomycin, the model shown in Fig. 10 is no longer applicable to
CHO or THP1, and complex I keeps on injecting electrons at a rate close
to that observed in the absence of sulﬁde. The explanation for that is
likely to be the reduction state of NAD and of complex I: when the
NADH/NAD ratio rises; the electrons coming out of complex I
becoming competitors against those coming out of SQR. An over-
reduced state of complex I is induced by factors that directly (rotenone
and sulﬁde in this study) or indirectly (oligomycin) act downstream of
complex I to inhibit electron transport in themitochondrial respiratory
chain. This is likely to explain the large difference in the time needed to
oxidize sulﬁde whether rotenone is present or not and when 53 pmol
of sulﬁde (26 µM) were added to the cells, leading to a drastic
inhibition of cytochrome oxidase (last addition in Fig. 2). However,
essentially no difference was observed, when the same amount was
infused at the fasted rate (166 pmol/(sml)), a conditionwhich ledonly
to a very partial inhibition of cytochrome oxidase. Oxidation seems to
be faster in absence of rotenone after the 166 pmol/(s ml) infusion.
This may however be explained by difﬁculties in determining the end
of sulﬁde oxidation or by the consequences on the plasma membrane
potential of the bioenergetic failure due to the presence of rotenone.
This model predicts the value of the oxygen consumption increase
in relation to the relative sulﬁde exposure (Fig. 10 bottom). These
predictionsweremet throughout the study: a relative sulﬁde exposure
of 0.5 caused a 25% increase of the oxygen consumption (Fig. 3) see
also Fig. 9. The upper limit of oxygen consumption in the presence of
sulﬁde represents three times the initial rate. This valuewas not vastly
different when compared to the one obtained in the experiments
made with a maximal dilution of THP1 cells which reduces the total
amount of sulﬁde and its metabolite present in the close chamber
(Fig. 11).The oxidation of sulﬁde consumes a lot of oxygen (Figs. 1 and 11).
This together with the relative inhibition of cytochrome oxidase
render cell phenotypes generating and oxidizing sulﬁde more subject
to oxygen shortage than others. This latter point is relevant to oxygen
sensing [24]. Our model (Fig. 10) predicts that in the basal state, the
increase in oxygen consumption reﬂects only the activity of the
dioxygenase. This dioxygenase together with a sulfur transferase
restores the SQR into a form able to accept again the two molecules of
H2S used for each catalytic cycle. The dioxygenase produces sulﬁte to
which a second sulfur atom is added by sulfur transferase to generate
thiosulfate (Fig. 1). Two reactions by the dioxygenase would also
oxidize the SSH groups on the SQR and liberate two sulﬁte anions
instead of thiosulfate. This would cause greater oxygen consumption
with a stoichiometry O2/H2S of 1.25. Interestingly, the mean values of
stoichiometry calculated with CHO or THP1 appeared slightly higher
thanwith theHT-29 colonic epithelial cells. These latter valuesmet the
values corresponding to the minimal oxygen consumption for sulﬁde
disposal within the presented models (Figs. 1 and 10).
Ourmodel (Fig. 10) predicts that the supply of a substratewith high
afﬁnity to themitochondrial respiratory chain did not increase the ﬂux
of electrons. It just switched the origin of electrons towards the most
efﬁcient substrate at the expense of the others. Hence, increased
substrate offer does not lead to waste of energy. On one hand, this
guarantees energetic efﬁciency andevidences a tightly coupled state of
mitochondria. On the other hand, this limits the detoxifying power of
Fig. 11. Maximal stimulation of cellular respiration by sulﬁde. This ﬁgure shows the
original data used to calculate the mean values shown in Fig. 3 with the human
monocyte cell line THP1. X axis : initial oxidation rate (JO2) of the cellular preparation
before sulﬁde addition (in pmol/(s ml)) which is directly proportional to the number of
cells used. Y axis maximal stimulation obtainedwith an optimal rate of sulﬁde injection.
There is a tendency for a higher stimulation when the cell number is low. A likely
explanation would be a low toxicity of the sulﬁde oxidation product(s) (presumably
thiosulfate+sulﬁte) that would obviously accumulate more when a larger number of
cells are present. Maximal values of stimulation approach the 300% value deduced as the
maximal possible stimulation according to the model (Fig. 6).
Fig. 12. How reverse electron transfer increases overall sulﬁde oxidation capacity. A
situation is schematized where the number of SQR enzymes (white box) is notably
lower than that of the other complexes of the mitochondrial respiratory chain (black:
complex I; gray complexes III and IV). Left: in the absence of reversion of complex I, the
coenzyme Q reduced by SQR may diffuse to another complex III remote from SQR
(dotted arrow). This diffusion is limited because it occurs within the phospholipid
bilayer of the inner membrane. Right: when complex I is reversed, it produces NADH
which is a hydrophilicmolecule that could easily reach another complex I (solid arrows).
It may also be oxidized through other pathways not ﬁgured in this scheme. This would
cause no change in stoichiometry as reverse ﬂux does not consume oxygen and simply
adds another source of NADH than the “carbon metabolism” schematized in Figs. 1
and 10.
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the colonocytes are able to escape this limitation by a remarkable
adjustment of their mitochondrial bioenergetics.
4.4. Reversion of mitochondrial complex I in colonocytes increases their
tolerance to sulﬁde
When stoichiometry was examined, the HT-29 cells differed from
the other cellular phenotypes in two ways: (i) Oligomycin caused no
change in stoichiometry in HT-29 cells (Fig. 7) exactly as if coupling
was altered and if complex I in the presence of oligomycin was still
unable to compete with SQR. (ii) The stoichiometry in the presence/
absence of rotenone did not evidence a competition between complex
I and SQR. Furthermore, no competition could be evidenced from the
shape of the stoichiometric curve as the decline did not occur earlier
in absence of rotenone. Moreover, when the effect of rotenone on
stoichiometry was studied in the presence of oligomycin (supple-
mentary information 3), no change was observed with the THP1 cells.
This is in contrast with what is observed in HT-29 cells. In these cells,
rotenone addition changed the shape of the curve towards a form
more similar to that obtained with THP1 cells. Finally, the study
of maximal ﬂuxes of oxygen and sulﬁde observable in HT29 cells led
to the conclusion that the activity of complex I is associated with
an uncoupled state of mitochondria and an increase in the sulﬁde
oxidation rate.
To propose a mechanism by which complex I would help in sulﬁde
oxidation in HT-29 cells, one should be reminded that complex I is a
reversible redox proton pump (supplementary information 4). This
reversionwould add a second fate for the electrons coming out of SQR,
the ﬁnal acceptors for the electrons of sulﬁde would then be NAD+
and oxygen. The NADH produced by the reversed complex I would
then be oxidized by another complex I remote from SQR. In the
context of a number of sulﬁde oxidizing units signiﬁcantly lower than
that of complexes I, III and IV this would increase mitochondrial
sulﬁde oxidation capacity (Fig. 12). Moreover, the re-entry of protonsthrough the reversed complex I would then be comparable to the
activity of an uncoupling protein as it dissipates the proton
electrochemical gradient generated by other respiratory complexes
working in “usual” mode. Therefore, the proposition of a reversion
capacity of complex I in HT-29 cells would explain both the uncoupled
state of mitochondria and the maintenance of a high sulﬁde oxidation
capacity in presence of oligomycin.
Consequently, in basal state, HT-29 colonic cells allow the SQR to
function at its maximal rate independently of the presence of other
substrates and cellular ATP needs. This appears to represent an elegant
and efﬁcient adaptive mechanism for a cell living in a sulﬁde-rich
environment and for which detoxiﬁcation of this metabolite is an
absolute priority. To our knowledge, this also provides theﬁrst evidence
for reverse electron transfer in intact cells. The additional conclusion is
that the other cell types examined here were unable to do reverse
electron transfer since in these cells complex I remained an opponent to
sulﬁde oxidation regardless of the presence or absence of oligomycin.
5. Conclusion
Our data provide evidence for a unique mitochondrial oxidation
pathway linked to cellular bioenergetics, detoxiﬁcation, cellular
signaling and physiology, together with the molecular identiﬁcation
of a key player in these processes whose importance was ignored up
to now: the mitochondrial SQR enzyme inherited from pre-photo-
synthetic times [13].
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